Compositions and methods for determining oocyte development potential
The present invention relates to the field of reproduction (e.g., human reproduction). In particular, the present invention provides markers (e.g., pentraxin 3 and Annexin A6), and methods of using the same to determine oocyte development potential. The present invention also provides compositions and methods for modifying oocyte development potential and assays (e.g., using markers of the present invention) for detecting gene expression associated with oocyte development potential. Such compositions and methods find use in diagnostic, research and therapeutic applications.
1. A method of characterizing oocyte development potential of an oocyte comprising providing cumulus cells harvested from an oocyte cumulus complex comprising said oocyte and measuring the expression level of pentraxin 3 and a BCL 2 family member in said cumulus cells.
2. A method of determining the likelihood of an oocyte to become fertilized comprising:
a) providing cumulus cells from an oocyte cumulus complex;
b) measuring the level of expression of pentraxin 3 and a BCL 2 family member in said cumulus cells; and
c) correlating said level of expression of said pentraxin 3 and said BCL 2 family member with the likelihood of said oocyte becoming fertilized.
3. A method of determining the likelihood of an oocyte implanting within the uterus of a female subject comprising:
a) providing cumulus cells from an oocyte cumulus complex;
b) measuring the level of expression of pentraxin 3 and a BCL 2 family member in said cumulus cells; and
c) correlating said level of expression of said pentraxin 3 and said BCL 2 family member with the likelihood of said oocyte implanting within the uterus of a female subject.